Shantanu Sengupta

Shantanu Sengupta


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2021 in Science
Verified
Journal Article
Open access
MDMahesh S. Dhar
Mahesh S. Dhar
RMRobin Marwal
Robin Marwal
RVRadhakrishnan Vs
Radhakrishnan Vs
KPKalaiarasan Ponnusamy
Kalaiarasan Ponnusamy
BJBani Jolly
Bani Jolly
SCSarah S. Cherian
Sarah S. Cherian
Deadly surge in Delhi: In the spring of 2021, Delhi, India experienced a wave of coronavirus cases that overwhelmed healthcare services despite the population showing a high level of immune positivity. Dhar et al . collated a mixture of serosurveillance, quantitative polymerase chain reaction, and genomic data, finding that waves of variants had passed through the Delhi population during 2020 and 2021. The alpha (B.1.1.7) variant dominated in March 2021 and was rapidly replaced by the delta (B.1.617.2) variant in April and May 2021. The delta variant outcompeted its predecessors by mutations that enhanced replication, immune evasion, and host receptor avidity, thus increasing transmissibility, reinfection, and vaccination breakthrough. —CA

9 September 2008 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
BPBhavana Prasher
Bhavana Prasher
SNSapna Negi
Sapna Negi
SAShilpi Aggarwal
Shilpi Aggarwal
AMAmit K Mandal
Amit K Mandal
TSTav P Sethi
Tav P Sethi
MMMitali Mukerji
Mitali Mukerji
Background: Ayurveda is an ancient system of personalized medicine documented and practiced in India since 1500 B.C. According to this system an individual's basic constitution to a large extent determines predisposition and prognosis to diseases as well as therapy and life-style regime. Ayurveda describes seven broad constitution types (Prakriti s) each with a varying degree of predisposition to different diseases. Amongst these, three most contrasting types, Vata, Pitta, Kapha, are the most vulnerable to diseases. In the realm of modern predictive medicine, efforts are being directed towards capturing disease phenotypes with greater precision for successful identification of markers for prospective disease conditions. In this study, we explore whether the different constitution types as described in Ayurveda has molecular correlates. Methods: Normal individuals of the three most contrasting constitutional types were identified following phenotyping criteria described in Ayurveda in Indian population of Indo-European origin. The peripheral blood samples of these individuals were analysed for genome wide expression levels, biochemical and hematological parameters. Gene Ontology (GO) and pathway based analysis was carried out on differentially expressed genes to explore if there were significant enrichments of functional categories among Prakriti types. Results: Individuals from the three most contrasting constitutional types exhibit striking differences with respect to biochemical and hematological parameters and at genome wide expression levels. Biochemical profiles like liver function tests, lipid profiles, and hematological parameters like haemoglobin exhibited differences between Prakriti types. Functional categories of genes showing differential expression among Prakriti types were significantly enriched in core biological processes like transport, regulation of cyclin dependent protein kinase activity, immune response and regulation of blood coagulation. A significant enrichment of housekeeping, disease related and hub genes were observed in these extreme constitution types. Conclusion: Ayurveda based method of phenotypic classification of extreme constitutional types allows us to uncover genes that may contribute to system level differences in normal individuals which could lead to differential disease predisposition. This is a first attempt towards unraveling the clinical phenotyping principle of a traditional system of medicine in terms of modern biology. An integration of Ayurveda with genomics holds potential and promise for future predictive medicine.

24 August 2012 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
SSSatish Sati
Satish Sati
SGSourav Ghosh
Sourav Ghosh
VJVaibhav Jain
Vaibhav Jain
VSVinod Scaria
Vinod Scaria
SSShantanu Sengupta
Shantanu Sengupta
A major fraction of the transcriptome of higher organisms comprised an extensive repertoire of long non-coding RNA (lncRNA) which express in a cell type and development stage-specific manner. While lncRNAs are a proven component of epigenetic gene expression modulation, epigenetic regulation of lncRNA itself remains poorly understood. Here we have analysed pan-genomic DNA methylation and histone modification marks (H3K4me3, H3K9me3, H3K27me3 and H3K36me3) associated with transcription start site (TSS) of lncRNA in four different cell types and three different tissue types representing various cellular stages. We observe that histone marks associated with active transcription H3K4me3 and H3K36me3 along with the repressive histone mark H3K27me3 have similar distribution pattern around TSS irrespective of cell types. Also, the density of these marks correlates well with expression of protein-coding and lncRNA genes. In contrast, the lncRNA genes harbour higher methylation density around TSS than protein-coding genes regardless of their expression status. Furthermore, we found that DNA methylation along with the other repressive histone mark H3K9me3 does not seem to play a role in lncRNA expression. Thus, our observation suggests that epigenetic regulation of lncRNA shares common features with mRNA except the role of DNA methylation which is markedly dissimilar.

23 January 2006 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
PSPriyanka Sharma
Priyanka Sharma
RSRd Senthilkumar
Rd Senthilkumar
VBVani Brahmachari
Vani Brahmachari
ESElayanambi Sundaramoorthy
Elayanambi Sundaramoorthy
AMAnubha Mahajan
Anubha Mahajan
SSShantanu Sengupta
Shantanu Sengupta
Homocysteine is an independent risk factor for cardiovascular diseases. It is also known to be associated with a variety of complex disorders. While there are a large number of independent studies implicating homocysteine in isolated pathways, the mechanism of homocysteine induced adverse effects are not clear. Homocysteine-induced modulation of gene expression through alteration of methylation status or by hitherto unknown mechanisms is predicted to lead to several pathological conditions either directly or indirectly. In the present manuscript, using literature mining approach, we have identified the genes that are modulated directly or indirectly by an elevated level of homocysteine. These genes were then placed in appropriate pathways in an attempt to understand the molecular basis of homocysteine induced complex disorders and to provide a resource for selection of genes for polymorphism screening and analysis of mutations as well as epigenetic modifications in relation to hyperhomocysteinemia. We have identified 135 genes in 1137 abstracts that either modulate the levels of homocysteine or are modulated by elevated levels of homocysteine. Mapping the genes to their respective pathways revealed that an elevated level of homocysteine leads to the atherosclerosis either by directly affecting lipid metabolism and transport or via oxidative stress and/or Endoplasmic Reticulum (ER) stress. Elevated levels of homocysteine also decreases the bioavailability of nitric oxide and modulates the levels of other metabolites including S-adenosyl methionine and S-adenosyl homocysteine which may result in cardiovascular or neurological disorders. The ER stress emerges as the common pathway that relates to apoptosis, atherosclerosis and neurological disorders and is modulated by levels of homocysteine. The comprehensive network collated has lead to the identification of genes that are modulated by homocysteine indicating that homocysteine exerts its effect not only through modulating the substrate levels for various catalytic processes but also through regulation of expression of genes involved in complex diseases.

1 May 2014 in Gene
Verified
Journal Article
Closed access
PSPriyanka Sharma
Priyanka Sharma
GGGaurav Garg
Gaurav Garg
AKArun Kumar
Arun Kumar
Mohammad FarhanMohammad Farhan
Mohammad Farhan
SKSudha Ramesh Kumar
Sudha Ramesh Kumar
SSShantanu Sengupta
Shantanu Sengupta

22 October 2005 in Journal of Human Genetics
Verified
Journal Article
Closed access
JKJitender Kumar
Jitender Kumar
SDSwapan Kumar Das
Swapan Kumar Das
PSPriyanka Sharma
Priyanka Sharma
GKGanesan Karthikeyan
Ganesan Karthikeyan
LRLakshmy Ramakrishnan
Lakshmy Ramakrishnan
SSShantanu Sengupta
Shantanu Sengupta